- Home
- TECH vs LNTH Comparison
TECH vs LNTH Comparison
Compare TECH & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- LNTH
- Stock Information
- Founded
- TECH 1976
- LNTH 1956
- Country
- TECH United States
- LNTH United States
- Employees
- TECH N/A
- LNTH N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- TECH Health Care
- LNTH Health Care
- Exchange
- TECH Nasdaq
- LNTH Nasdaq
- Market Cap
- TECH 7.8B
- LNTH 7.5B
- IPO Year
- TECH 1989
- LNTH 2015
- Fundamental
- Price
- TECH $49.15
- LNTH $81.24
- Analyst Decision
- TECH Buy
- LNTH Strong Buy
- Analyst Count
- TECH 10
- LNTH 5
- Target Price
- TECH $73.44
- LNTH $133.80
- AVG Volume (30 Days)
- TECH 2.3M
- LNTH 1.4M
- Earning Date
- TECH 05-07-2025
- LNTH 05-07-2025
- Dividend Yield
- TECH 0.65%
- LNTH N/A
- EPS Growth
- TECH N/A
- LNTH N/A
- EPS
- TECH 0.83
- LNTH 3.53
- Revenue
- TECH $1,208,770,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- TECH $8.19
- LNTH $4.96
- Revenue Next Year
- TECH $8.61
- LNTH $10.25
- P/E Ratio
- TECH $59.07
- LNTH $23.00
- Revenue Growth
- TECH 4.72
- LNTH 12.53
- 52 Week Low
- TECH $46.44
- LNTH $74.34
- 52 Week High
- TECH $85.57
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- TECH 44.74
- LNTH 32.82
- Support Level
- TECH $46.35
- LNTH $77.01
- Resistance Level
- TECH $54.40
- LNTH $83.60
- Average True Range (ATR)
- TECH 2.17
- LNTH 3.77
- MACD
- TECH 0.27
- LNTH -2.21
- Stochastic Oscillator
- TECH 34.78
- LNTH 13.26
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.